Influenza: Cost of Illness and Considerations in the Economic Evaluation of New and Emerging Therapies

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.19, Iss.3, 2001-03, pp. : 223-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C: Cost of Illness and Considerations for the Economic Evaluation of Antiviral Therapies

By Wong John B.

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 661-672

Adis International

Access to resources Recommend Favorite

Enteroviral Meningitis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Parasuraman T.V.

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 3-12

Adis International

Access to resources Recommend Favorite

Cystic Fibrosis: Cost of Illness and Considerations for the Economic Evaluation of Potential Therapies

By Krauth C.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1001-1024

Adis International

Access to resources Recommend Favorite

Acute Pyelonephritis Among Adults: Cost of Illness and Considerations for the Economic Evaluation of Therapy

By Brown Patricia

PharmacoEconomics, Vol. 23, Iss. 11, 2005-01 ,pp. : 1123-1142

Adis International

Access to resources Recommend Favorite

Recent Strategies in the Search for New Anti-Influenza Therapies

Current Drug Targets, Vol. 4, Iss. 5, 2003-07 ,pp. : 389-408

Bentham Science Publishers

Access to resources Recommend Favorite